Accessibility Menu
Clover Health Investments, Corp. logo

Clover Health Investments, Corp.(NASDAQ) CLOV

Market Cap$2.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-59%
5 Year-51%
1 Year+61%
1 Month+0%
Premium Feature
Moneyball Superscore
52/100
$4.23
+0.00%
+0.00Today
After hours$4.23-$0.00 (-0.12%)
Clover Health Investments, Corp. last closing stock price
MetricPriceDate
Last closeUSD 4.232026-08-28
Clover Health Investments, Corp. stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.93%USD 4.152026-08-21
1 month+0%USD 4.232026-07-29
3 month+6.28%USD 3.982026-05-29
Year to date+80%USD 2.352025-12-31
1 year+60.84%USD 2.632025-08-28
3 year+208.76%USD 1.372023-08-29
5 year-50.87%USD 8.612021-08-27
Since inception-58.53%USD 10.202020-06-12

Clover Health Investments, Corp. Financials at a Glance

Market Cap

$2.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.48B

Net Income (TTM)

-$18.36M

EPS (TTM)

-$0.04

P/E Ratio

-105.22

Dividend

$0.00

Beta (Volatility)

1.55 (High)

Price

$4.23

Volume

4,178,778.437

Open

$4.18

Previous Close

$4.23

Daily Range

$4.17 - $4.29

52-Week Range

$1.58 - $5.59

Estimated Earnings Date

Nov 4, 2026

About Clover Health Investments, Corp.

Clover Health Investments, Corp. sells health insurance plans to seniors. Its technology helps doctors find and treat illnesses earlier. This makes medical care more personalized and affordable.

What Clover Health Offers

  • PPO Plans: Flexible Preferred Provider Organization insurance that lets members choose their own doctors; considered the flagship product.
  • HMO Plans: Health Maintenance Organization plans that provide medical care through a specific network of providers.
  • Clover Assistant: Software that gives physicians data insights to manage chronic diseases; licensed externally as Counterpart Assistant.
  • Medicare Advantage: Private health coverage for individuals eligible for Medicare; represented $1.5 billion in revenue for the six months ended June 30, 2026.

Growing the Care Network

  • Reached a total of 157,309 Medicare Advantage members by June 30, 2026.
  • Won a court judgment in June 2026 that prompted the government to recalculate plan quality ratings.
  • Increased the 2026 Star Rating for its PPO and HMO contracts to 4.5 Stars for payment year 2027.
  • Expanded the use of its technology platform by licensing software to external health organizations.

How This Company Stands Out

The company uses its proprietary Clover Assistant platform to provide doctors with personalized patient data. It also offers lower out-of-pocket costs for primary care compared to similar market plans.

The Financial Scorecard

  • Total revenues reached $1.5 billion for the six months ended June 30, 2026, up 59% year over year.
  • Adjusted EBITDA, a non-GAAP measure, rose to $81.2 million for the six months ended June 30, 2026.
  • Income from operations was $55.3 million for the six months ended June 30, 2026, compared to a loss in 2025.
  • Cash, cash equivalents, and investments totaled $443.0 million as of June 30, 2026.
  • Net medical claims incurred increased 61% to $1.2 billion for the six months ended June 30, 2026.

The Final Word

Clover Health has transitioned from operating losses to profitability by expanding its membership and leveraging its proprietary data platform. The company continues to focus on technology to manage medical costs and improve health outcomes for seniors.

AI Generated • Aug 7, 2026

Industry

Healthcare Providers and Services

Employees

724

CEO

Andrew Toy

Headquarters

Wilmington, DE 19801, US

CLOV Financials

Key Financial Metrics (TTM)

Gross Margin

18.57%

Operating Margin

-0.74%

Net Income Margin

-0.74%

Return on Equity

-5.38%

Return on Capital

-27.71%

Return on Assets

-2.55%

Earnings Yield

-0.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

531.16M

Volume

4.18M

Avg. Volume

6.18M

Financials (TTM)

Gross Profit

$459.93M

Operating Income

-$18.36M

EBITDA

-$16.46M

Operating Cash Flow

$77.03M

Capital Expenditure

-$2.83M

Free Cash Flow

$74.21M

Cash & ST Invst.

$201.32M

Total Debt

$0.00

Clover Health Investments, Corp. Performance Analysis

Clover Health Investments, Corp. annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 3,486,804,000126.7%
20232023-12-31USD 1,255,731,000-64.0%
20242024-12-31USD 1,370,614,0009.1%
20252025-12-31USD 1,924,288,00040.4%
Clover Health Investments, Corp. sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-304.0%
Q42025-12-31-1.8%
Q12026-03-3153.6%
Q22026-06-30-0.8%
Clover Health Investments, Corp. annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.71-49.9%
20232023-12-31USD -0.44-37.9%
20242024-12-31USD -0.09-80.2%
20252025-12-31USD -0.1790.3%
Clover Health Investments, Corp. sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-128.4%
Q42025-12-31-100.8%
Q12026-03-31153.8%
Q22026-06-30-2.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$743.17M

+55.6%

Gross Profit

$153.00M

+53.6%

Gross Margin

20.59%

N/A

Market Cap

$2.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.10M

N/A

Employees

724

N/A

Net Income

$28.00M

+364.7%

EBITDA

$28.57M

+380.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$201.32M

+0.9%

Total Debt

$0.00

N/A

Accounts Receivable

$202.74M

+54.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-2.55%

N/A

Return on Invested Capital

-4.62%

N/A

Free Cash Flow

$24.51M

+406.4%

Operating Cash Flow

$25.19M

+365.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRDNGuardian Pharmacy Services, Inc.
$37.06-0.72%
GPCRStructure Therapeutics Inc.
$47.37-3.76%
CERTCertara, Inc.
$8.35-0.71%
PRCTPROCEPT BioRobotics Corporation
$20.83+1.12%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$217.55-0.05%
PCGPG&E
$16.60-0.08%
BITOProShares Trust - ProShares Bitcoin ETF
$10.45-0.03%
IRENIren
$35.45-0.13%

Questions About CLOV

What is the current price of Clover Health Investments, Corp.?

Clover Health Investments, Corp. is trading at $4.23 per share.

What is the 52-week range for Clover Health Investments, Corp.?

Over the past 52 weeks, Clover Health Investments, Corp. has traded between $1.58 and $5.59.

How much debt does Clover Health Investments, Corp. have?

As of the most recent reporting period, Clover Health Investments, Corp. reported total debt of $0.00.

How much cash does Clover Health Investments, Corp. have on hand?

Clover Health Investments, Corp. reported $198.84M in cash and cash equivalents in its most recent financial results.

What is Clover Health Investments, Corp.’s dividend yield?

Clover Health Investments, Corp. does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.